van den Heuvel et al.
8.43 (s, 2H), 8.49 (s, 2H). 13C NMR (CDCl3, 75.5 MHz): δ -5.4,
18.2, 25.8, 56.6, 62.6, 62.6, 71.0, 122.3, 123.4, 134.1, 134.4,
134.5, 134.7, 147.0, 147.2, 158.6, 158.7. ESI-MS: [M + H]+
calcd for C51H86N5O4Si4 m/z 944.8, found 944.6.
(s, 2H), 8.34 (s, 2H). 13C NMR (CDCl3, 75.5 MHz): δ 30.5, 30.6,
32.5, 32.6, 33.3, 33.4, 56.6, 71.1, 122.3, 123.4, 133.6, 133.8,
136.1, 136.2, 148.8, 149.1, 157.5, 157.7. ESI-MS: [M + H]+
calcd for C35H42N5Br4 m/z 848.0, found 848.0.42
Tetr a cystein e N4P y Der iva tive 1d . Methyl N-acetylcys-
teine (114 mg, 0.64 mmol) was dissolved in nitrogen-purged
DMF (1 mL) and titrated with a Cs2CO3 solution (∼100 mg/
mL) to pH 9 under a nitrogen atmosphere. A solution of 27
(53 mg, 0.062 mmol) in DMF (1 mL) was added, and the
mixture was stirred at room temperature overnight. The
solution was diluted with water and lyophilized. The brown
residue was purified by preparative reverse-phase HPLC with
a gradient of 0.05 M ammonium acetate/MeCN (50:50) to 100%
MeCN over 10 min. The product eluted at tR ) 7.2 min, was
collected and lyophilized to yield a brown oil (9.5 mg, 12%).
1H NMR (CDCl3, 500 MHz): δ 1.88 (m, 8H), 2.04 (s, 12H), 2.55
(m, 8H), 2.68 (m, 8H), 3.00 (m, 8H), 3.78 (m, 12H), 3.90 (s,
4H), 4.83 (m, 4H), 5.28 (s, 1H), 6.39 (br‚d, 4H), 7.47 (m, 8H),
8.35 (s, 2H), 8.41 (s, 2H). ESI-MS: [M + H]+ calcd for
[6-[[[Bis[5-(h ydr oxym eth yl)-2-pyr idin yl]m eth yl][[5-(h y-
d r oxym eth yl)-2-p yr id in yl]m eth yl]a m in o]m eth yl]-3-p yr -
id in yl]m eth a n ol (25). Dilute HCl (2 mL, 1 M) was added to
a solution of 23 (0.22 g, 0.23 mmol) in ethanol (10 mL). After
0.5 h, the reaction mixture was extracted with diethyl ether.
The aqueous layer was neutralized with solid Na2CO3 and
lyophilized or azeotropically removed with ethanol. The residue
was taken up in dry ethanol, and after filtration and evapora-
tion of the solvent 25 was obtained as a viscous brown,
hygroscopic oil (0.12 g, 100%). 1H NMR (CD3OD, 300 MHz):
δ 3.86 (s, 4H), 4.58 (s, 4H), 4.91 (s, 4H), 5.32 (s, 1H), 7.39 (d,
J ) 8.1 Hz, 2H), 7.63 (d, J ) 8.1 Hz, 4H), 7.73 (d, J ) 8.1 Hz,
1H), 7.74 (d, J ) 8.1 Hz, 1H), 8.38 (s, 2H), 8.49 (s, 2H). 13C
NMR (CD3OD, 75.5 MHz): δ 58.3, 62.3, 62.4, 74.3, 124.6,
125.3, 137.0, 137.0, 137.1, 137.7, 148.7, 149.3, 158.8, 159.4.
ESI-MS: [M + H]+ calcd for C27H30N5O4 m/z 488.2, found
488.0.
C
59H82N9O12S4 m/z 1236.5, found 1236.1.
Tetr a p ep tid e N4P y d er iva tive 2e was first prepared as
described for 1d , using the peptide sequence Ac-Cys-Gly-Leu-
His-Glu-Leu-Leu-Lys-Gly-NH2.43 After stirring overnight, the
solution was acidified with 0.1% TFA in water and Fe(ClO4)2
(1.1 equiv) was added as a solution in MeCN. The orange/red
solution was purified by preparative reverse-phase HPLC
using a linear gradient of 20-40% solvent B over 10 min. The
product eluted at tR ) 8.6 min and was collected and lyophi-
lized to yield a yellow/orange solid (2.1 mg, 18%). MALDI:
calcd for [M - 2(ClO4)- - (MeCN)]2+ m/z 4620.38 (monoiso-
topic), 4623.43 (average isotope composition), found 4619.2.
Bis(5-br om o-2-p yr id in yl)m eth a n on e (30). To a suspen-
sion of 2,5-dibromopyridine (10.7 g, 44.3 mmol) in dry toluene
(1 L) at -80 °C was slowly added n-BuLi (29 mL, 46 mmol,
1.05 equiv) under a nitrogen atmosphere. After 2 h at -80 °C
the reaction was quenched with freshly distilled diethyl
carbonate (2.7 mL, 22 mmol, 0.5 equiv). After further workup
and extractions using ethyl acetate, removal of the solvent
furnished a dark brown oil, which solidified on standing. By
triturating the crude product with diethyl ether pure 30 was
obtained as a light brown solid (2.77 g, 37%). Recrystallization
from diethyl ether afforded the analytically pure product.
Mp: 191.8-192.7 °C. 1H NMR (CDCl3, 300 MHz): δ 7.98 (d, J
) 8.2 Hz, 2H), 8.03 (dd, J ) 8.2, 2.0 Hz, 2H), 8.77 (d, J ) 2.0
Hz, 2H). 13C NMR (CDCl3, 50.3 MHz): δ 124.7, 126.3, 139.4,
150.3, 152.1, 191.0. HRMS: calcd for C11H6N2OBr2 339.885,
found 339.885. Anal. Calcd for C11H6N2OBr2: C, 38.60; H, 1.80;
N, 8.20; Br, 46.70. Found: C, 38.33; H, 1.80; N, 8.01; Br, 47.04.
Bis(5-br om o-2-pyr idin yl)m eth an on e Oxim e (31). A mix-
ture of 30 (2.77 g, 8.10 mmol), hydroxylammonium chloride
(3.0 g, 42 mmol, 5 equiv), and pyridine (3.4 mL, 42 mmol, 5
equiv) in ethanol (60 mL) was refluxed for 1.5 h and subse-
quently cooled to room temperature. The mixture was poured
into ice-water and stirred in an ice bath for 1 h. The solids
were collected by filtration and washed with cold dilute ethanol
(50%). After drying in air the product was obtained as a light
brown solid (2.63 g, 91%). Recrystallization from ethanol/water
afforded analytically pure 31 as fine, lilac/grey needles. Mp:
N-[Bis[5-(m et h oxym et h yl)-2-p yr id in yl]m et h yl]-N,N-
bis[[5-(m eth oxym eth yl)-2-p yr id in yl]m eth yl]a m in e (1c).
To a stirred suspension of NaH (55 mg, 1.4 mmol, 8 equiv) in
dry DMF (1 mL) at 0 °C was added a solution of 25 (83 mg,
0.17 mmol) in dry DMF (1 mL). After 30 min, MeI (85 µL, 1.4
mmol, 8 equiv) was added at 0 °C. The reaction mixture was
allowed to warm to room temperature and stirred for 2 h.
Water was added and the mixture extracted with CH2Cl2. The
organic layer was washed with water and brine. After drying
over Na2SO4 and evaporation of the solvent, the product was
obtained as a red/brown oil (83 mg, 89%). Purification by flash
column chromatography over alumina using hexane/ethyl
acetate/TEA (10:18:2) yielded 1c as a light brown oil (37 mg,
40%). 1H NMR (CDCl3, 300 MHz): δ 3.33 (s, 12 H), 3.91 (s,
4H), 4.83 (s, 8H), 5.30 (s, 1H), 7.60 (s, 4H), 7.62 (s, 4H), 8.40
(s, 2H), 8.46 (s, 2H). 13C NMR (CDCl3, 75.5 MHz): δ 56.8, 58.1,
58.2, 71.4, 71.9, 122.5, 123.5, 131.4, 131.7, 135.7, 135.8, 148.4,
148.6, 159.3, 159.4. ESI-MS: [M + H]+ calcd for C31H38N5O4
m/z 544.3, found 544.4.
[(1c)F e(MeCN)](ClO4)2 (2c). To a solution of 1c (32 mg,
0.059 mmol) in acetonitrile (1.5 mL) was added Fe(ClO4)2‚H2O
(17 mg, 0.066 mmol, 1.1 equiv). The deep red solution was
placed in a sealed container, and ethyl acetate was allowed to
diffuse slowly into the solution. A dark red oil was formed after
1 week. The solution was removed and the oil dissolved in
acetonitrile. A fine red powder was formed which was isolated
and redissolved in acetonitrile. Slow diffusion of ethyl acetate
provided 2c as red crystals after 2 weeks (9 mg, 18%). 1H NMR
(CD3CN, 300 MHz): δ 3.29 (s, 6H), 3.34 (s, 6H), 4.32 (dd, J AB
) 27.9, 8.1 Hz, 4H), 4.38 (s, 4H), 4.47 (s, 4H), 6.31 (s, 1H),
7.04 (d, J ) 8.1 Hz, 2H), 7.63 (d, J ) 7.7 Hz, 2H), 7.85 (m,
4H), 8.82 (s, 2H), 8.92 (s, 2H). ESI-MS: [M - (ClO4)-
-
(MeCN)]+ calcd for C31H38ClFeN5O8 m/z 698.2, found 698.0;
[M - 2(ClO4)-]2+ calcd for C33H40FeN6O4 m/z 320.1, found
320.3; [M - 2(ClO4)- - (MeCN)]2+ calcd for C31H37FeN5O4 m/z
299.6, found 300.0.
N-[Bis[5-(3-br om op r op yl)-2-p yr id in yl]m eth yl]-N,N-bis-
[[5-(3-br om op r op yl)-2-p yr id in yl]m eth yl]a m in e (27). PPh3-
Br2 was freshly prepared by the addition of Br2 (75 µL, 1.4
mmol, 4.7 equiv) to a stirred solution of Ph3P (395 mg, 1.51
mmol, 5. equiv) in dry CH2Cl2 (1 mL) under a nitrogen
atmosphere. To the resulting yellow suspension was added a
solution of 24 (321 mg, 0.304 mmol) in dry CH2Cl2 (1 mL).
The reaction mixture was stirred at room temperature until
all the solids had disappeared (2 days) and extracted with 1
M HCl. The aqueous layer was neutralized with solid NaHCO3
and extracted with CH2Cl2. The organic layer was washed with
brine and dried over Na2SO4. Evaporation of the solvent
1
191.1-191.7 °C. H NMR (CD3OD, 300 MHz): δ 7.63 (d, J )
8.4 Hz, 1H), 7.76 (d, J ) 8.4 Hz, 1H), 7.92 (dd, J ) 8.4, 1.8 Hz,
1H), 7.99 (dd, J ) 8.4, 1.8 Hz, 1H), 8.65 (d, J ) 1.8 Hz, 1H),
1
8.70 (d, J ) 1.8 Hz, 1H). H NMR (CD3OD, 300 MHz): δ 7.56
(d, J ) 8.4 Hz, 1H), 7.83 (d, J ) 8.4 Hz, 1H), 8.01 (dd, J ) 8.4,
2.2 Hz, 1H), 8.10 (dd, J ) 8.4, 2.2 Hz, 1H), 8.50 (d, J ) 2.2 Hz,
1H), 8.68 (d, J ) 2.2 Hz, 1H). 13C NMR (CDCl3, 50.3 MHz): δ
119.8, 120.3, 122.8, 127.0, 138.7, 139.4, 149.5, 150.0, 150.6,
153.0, 153.9. HRMS: calcd for C11H7N3OBr2 354.895, found
(42) Observed isotope pattern corresponds to the calculated isotope
pattern.
(43) The peptide was synthesized by standard automated methods
on a peptide synthesizer using Fmoc-protected amino acids and purified
by preparative reversed-phase HPLC.
1
afforded 27 as a red oil (190 mg, 74%). H NMR (CDCl3, 300
MHz): δ 2.07 (t, J ) 6.6 Hz, 8H), 2.67 (t, J ) 6.6 Hz, 8H),
3.32 (m, 8H), 3.84 (s, 4H), 5.22 (s, 1H), 7.34-7.58 (m, 8H), 8.28
260 J . Org. Chem., Vol. 69, No. 2, 2004